StonvexLoading…
StonvexStonvexStonvexCore line items from OGE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $736.70M | $3.19B | $2.49B | $1.46B |
Operating Income | $113.10M | $799.40M | $661.20M | $319.90M |
Net Income | $50.20M | $470.70M | $401.50M | $170.20M |
EPS (Diluted) | $0.24 | $2.32 | $1.99 | $0.84 |
Total Assets | $14.47B | $14.37B | $14.26B | $14.09B |
Total Liabilities | $9.53B | $9.39B | $9.46B | $9.44B |
Cash & Equivalents | $200.00K | $200.00K | $300.00K | $500.00K |
Free Cash Flow OCF − CapEx | $-91.30M | $82.70M | $-400.00K | $-168.70M |
Shares Outstanding | 207.20M | 206.10M | 202.00M | 202.00M |